Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blueprint Medicines

127.85
-0.0500-0.04%
Post-market: 127.76-0.0900-0.07%19:58 EDT
Volume:3.07M
Turnover:392.43M
Market Cap:8.27B
PE:-52.11
High:128.07
Open:128.07
Low:127.77
Close:127.90
Loading ...

BRIEF-Blueprint Medicines Q4 Net Income USD -49.956 Million Vs. IBES Estimate USD -44.7 Million

Reuters
·
13 Feb

Blueprint Medicines Q4 Net Income USD -49.956 Million VS. Ibes Estimate USD -44.7 Million

THOMSON REUTERS
·
13 Feb

Earnings Preview: Axsome Therapeutics (AXSM) Q4 Earnings Expected to Decline

Zacks
·
11 Feb

Barclays Keeps Their Hold Rating on Blueprint Medicines (BPMC)

TIPRANKS
·
11 Feb

JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)

TIPRANKS
·
07 Feb

Will Blueprint Medicines (BPMC) Report Negative Earnings Next Week? What You Should Know

Zacks
·
06 Feb

Should You Buy Blueprint Medicines (BPMC) After Golden Cross?

Zacks
·
06 Feb

Blueprint Medicines Is Maintained at Overweight by JP Morgan

Dow Jones
·
04 Feb

Blueprint Medicines Is Maintained at Neutral by Piper Sandler

Dow Jones
·
27 Jan

Blueprint Medicines price target raised to $119 from $109 at Piper Sandler

TIPRANKS
·
27 Jan

Why Blueprint Medical (BPMC) Is Skyrocketing Now

Insider Monkey
·
26 Jan

BUZZ-Leerink Partners raises PT on Blueprint Medicines

Reuters
·
15 Jan

Cautious Hold Rating for Third Harmonic Bio Amid Competitive Pressure from Blueprint Medicines

TIPRANKS
·
15 Jan

Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy

Zacks
·
14 Jan

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

Zacks
·
14 Jan

Blueprint Medicines Corp : Leerink Partners Raises Target Price to $98 From $89

THOMSON REUTERS
·
14 Jan

Blueprint Medicines (BPMC) Stock Jumps 18.2%: Will It Continue to Soar?

Zacks
·
14 Jan

Blueprint Medicines Shares Jump on View That Ayvakit Could Hit $2B in Revenue by 2030

Dow Jones
·
14 Jan

Blueprint Medicines Highlights 2024 Achievements and Future Growth

TIPRANKS
·
14 Jan

Blueprint Medicines Expects Systemic Mastocytosis Franchise to Generate $4 Billion by 2030 -- Shares Up

MT Newswires Live
·
14 Jan